ahlam1399
09-04-2015, 03:13 PM
Roche hemophilia drug wins fast-track FDA designation
ZURICH (Reuters) - Roche said on Friday it had won breakthrough therapy designation from the U.S. Food and Drug Administration for an experimental hemophilia medicine, aiming for a piece of the $11 billion hemophilia drug market.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4990a38a/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=ExW_16IX6D8:u8_fepgD8hc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ExW_16IX6D8:u8_fepgD8hc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=ExW_16IX6D8:u8_fepgD8hc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ExW_16IX6D8:u8_fepgD8hc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=ExW_16IX6D8:u8_fepgD8hc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/ExW_16IX6D8
ZURICH (Reuters) - Roche said on Friday it had won breakthrough therapy designation from the U.S. Food and Drug Administration for an experimental hemophilia medicine, aiming for a piece of the $11 billion hemophilia drug market.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4990a38a/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=ExW_16IX6D8:u8_fepgD8hc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ExW_16IX6D8:u8_fepgD8hc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=ExW_16IX6D8:u8_fepgD8hc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ExW_16IX6D8:u8_fepgD8hc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=ExW_16IX6D8:u8_fepgD8hc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/ExW_16IX6D8